These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19836926)

  • 21. Unilateral temporal muscle hypertrophy: a rare clinical entity.
    Lowry TR; Helling E
    Ear Nose Throat J; 2003 Mar; 82(3):198-9. PubMed ID: 12696240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin as an alternative for the treatment of aesthetic deformities.
    Barbosa MV; Nahas FX; Ferreira LM; Al-Ahmad HT; Al-Qudah M
    Saudi Med J; 2006 Oct; 27(10):1613; author reply 1613. PubMed ID: 17013500
    [No Abstract]   [Full Text] [Related]  

  • 23. Meige syndrome: a rare form of cranial dystonia that was treated successfully with botulinum toxin.
    Sabesan T
    Br J Oral Maxillofac Surg; 2008 Oct; 46(7):588-90. PubMed ID: 18346825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin type A for the treatment of nummular headache: four case studies.
    Mathew NT; Kailasam J; Meadors L
    Headache; 2008 Mar; 48(3):442-7. PubMed ID: 18028377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of facial chromhidrosis with botulinum toxin type A.
    Matarasso SL
    J Am Acad Dermatol; 2005 Jan; 52(1):89-91. PubMed ID: 15627085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of chronic plantar fasciitis with botulinum toxin A: an open case series with a 1 year follow up.
    Placzek R; Deuretzbacher G; Buttgereit F; Meiss AL
    Ann Rheum Dis; 2005 Nov; 64(11):1659-61. PubMed ID: 16227422
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of unilateral masseter hypertrophy with botulinum toxin in two cases.
    Işeri M; Işeri PK
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(3-4):99-102. PubMed ID: 16010109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic external ophthalmoplegia with bilateral retrobulbar botulinum toxin- an effective treatment for acquired nystagmus with oscillopsia.
    Menon GJ; Thaller VT
    Eye (Lond); 2002 Nov; 16(6):804-6. PubMed ID: 12439689
    [No Abstract]   [Full Text] [Related]  

  • 29. Peculiar presentation of bilateral temporalis muscle hypertrophy--report of a case and review of literature.
    Pasupathy S; Yuvaraj V
    Oral Maxillofac Surg; 2010 Sep; 14(3):183-5. PubMed ID: 20099005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin A injections for the treatment of Schwartz-Jampel syndrome: a case series.
    Aburahma SK; Al-Khateeb T; Alrefai A; Amarin Z
    J Child Neurol; 2009 Jan; 24(1):5-8. PubMed ID: 19168812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Masseteric hypertrophy: considerations regarding treatment planning decisions and introduction of a novel surgical technique.
    Pary A; Pary K
    J Oral Maxillofac Surg; 2011 Mar; 69(3):944-9. PubMed ID: 21195532
    [No Abstract]   [Full Text] [Related]  

  • 32. [Botulinum toxin A--therapy option in cases of chronic plantar fasciitis?--an open treatment attempt with 9 patients and a one year observation period].
    Z Orthop Ihre Grenzgeb; 2005; 143(2):145-8. PubMed ID: 15849625
    [No Abstract]   [Full Text] [Related]  

  • 33. Botulinum toxin A therapy for medial rectus injury during endoscopic sinus surgery.
    Hong JE; Goldberg AN; Cockerham KP
    Am J Rhinol; 2008; 22(1):95-7. PubMed ID: 18284867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spasmodic torticollis associated with multiple sclerosis: report of two cases.
    Svetel M; Sternic N; Filipovic S; Kostic V
    Mov Disord; 1997 Nov; 12(6):1092-4. PubMed ID: 9399247
    [No Abstract]   [Full Text] [Related]  

  • 35. Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache.
    Mathew NT; Kailasam J; Meadors L
    Headache; 2008 Feb; 48(2):194-200. PubMed ID: 17868356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of botulinum toxin type A injection into human masseter muscle on stimulated parotid saliva flow rate.
    Kwon JS; Kim ST; Jeon YM; Choi JH
    Int J Oral Maxillofac Surg; 2009 Apr; 38(4):316-20. PubMed ID: 19231136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolated unilateral temporalis muscle hypertrophy in a child: a case report with literature review.
    Ranasinghe JC; Wickramasinghe C; Rodrigo G
    BMC Pediatr; 2018 Feb; 18(1):71. PubMed ID: 29458353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moving ear syndrome: the role of botulinum toxin.
    Godeiro-Junior C; Felicio AC; Felix EP; Manzano GM; Silva SM; Borges V; Ferraz HB; Barsottini OG
    Mov Disord; 2008 Jan; 23(1):122-4. PubMed ID: 17960817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paradoxical use of frontalis muscle and the possible role of botulinum a toxin in permanent motor relearning.
    Ben Simon GJ; Blaydon SM; Schwarcz RM; Nakra T; Goldberg RA; McCann JD
    Ophthalmology; 2005 May; 112(5):918-22. PubMed ID: 15878076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of primary writing tremor with botulinum toxin type a injections: report of a case series.
    Papapetropoulos S; Singer C
    Clin Neuropharmacol; 2006; 29(6):364-7. PubMed ID: 17095901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.